Literature DB >> 15928941

[Growth hormone therapy in adults].

P H Kann1.   

Abstract

In adult patients with growth hormone deficiency due to organic hypopituitarism, substitution with growth hormone is very useful and well established. Positive influence on numerous target parameters has been investigated in randomised controlled trials (evidence level I) and could be documented. Thus, growth hormone substitution in hypopituitarism is scientifically founded and has been admitted by the authorities in the European Union. Concerning pharmacotherapy with growth hormone in healthy elderly persons without pituitary disease and also doping in sports, the situation is completely different. Use of growth hormone in these circumstances has not sufficiently been investigated concerning indications, efficacy and safety. Ethical and economical aspects have not been evaluated yet. Serious concerns about the therapeutic safety need to be considered.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15928941     DOI: 10.1007/s00108-005-1426-5

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  13 in total

1.  Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society.

Authors: 
Journal:  J Clin Endocrinol Metab       Date:  2000-11       Impact factor: 5.958

2.  Growth hormone administration and exercise effects on muscle fiber type and diameter in moderately frail older people.

Authors:  J V Hennessey; J A Chromiak; S DellaVentura; S E Reinert; J Puhl; D P Kiel; C J Rosen; H Vandenburgh; D B MacLean
Journal:  J Am Geriatr Soc       Date:  2001-07       Impact factor: 5.562

3.  Effects of GH and/or sex steroid administration on abdominal subcutaneous and visceral fat in healthy aged women and men.

Authors:  T Münzer; S M Harman; P Hees; E Shapiro; C Christmas; M F Bellantoni; T E Stevens; K G O'Connor; K M Pabst; C St Clair; J D Sorkin; M R Blackman
Journal:  J Clin Endocrinol Metab       Date:  2001-08       Impact factor: 5.958

Review 4.  IGF-1 signaling and aging.

Authors:  Martin Holzenberger; Laurent Kappeler; Carlos De Magalhaes Filho
Journal:  Exp Gerontol       Date:  2004 Nov-Dec       Impact factor: 4.032

5.  Critical evaluation of the safety of recombinant human growth hormone administration: statement from the Growth Hormone Research Society.

Authors: 
Journal:  J Clin Endocrinol Metab       Date:  2001-05       Impact factor: 5.958

6.  Effects of human growth hormone in men over 60 years old.

Authors:  D Rudman; A G Feller; H S Nagraj; G A Gergans; P Y Lalitha; A F Goldberg; R A Schlenker; L Cohn; I W Rudman; D E Mattson
Journal:  N Engl J Med       Date:  1990-07-05       Impact factor: 91.245

7.  Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study.

Authors:  Georg Brabant; Alexander von zur Mühlen; Christian Wüster; Michael B Ranke; Jürgen Kratzsch; Wieland Kiess; Jean-Marie Ketelslegers; Lars Wilhelmsen; Lena Hulthén; Bernhard Saller; Anders Mattsson; Jürgen Wilde; Rudolf Schemer; Peter Kann
Journal:  Horm Res       Date:  2003

8.  Life span extension by reduction of the growth hormone-insulin-like growth factor-1 axis: relation to caloric restriction.

Authors:  Isao Shimokawa; Yoshikazu Higami; Tomoshi Tsuchiya; Hiroshi Otani; Toshimitsu Komatsu; Takuya Chiba; Haruyoshi Yamaza
Journal:  FASEB J       Date:  2003-04-08       Impact factor: 5.191

9.  Growth hormone replacement in healthy older men improves body composition but not functional ability.

Authors:  M A Papadakis; D Grady; D Black; M J Tierney; G A Gooding; M Schambelan; C Grunfeld
Journal:  Ann Intern Med       Date:  1996-04-15       Impact factor: 25.391

10.  Can growth hormone (GH) accelerate aging? Evidence from GH-transgenic mice.

Authors:  Andrzej Bartke
Journal:  Neuroendocrinology       Date:  2003-10       Impact factor: 4.914

View more
  2 in total

1.  Interdental spacing and orthodontic treatment in competitive athletes: clues to doping with growth hormones?

Authors:  Jens Christoph Türp; Heinz Lünsch; Ralf Johannes Radlanski
Journal:  J Orofac Orthop       Date:  2010-10-21       Impact factor: 1.938

Review 2.  [Growth hormone therapy in adult patients: a review].

Authors:  Peter Herbert Kann
Journal:  Wien Klin Wochenschr       Date:  2011-05-18       Impact factor: 1.704

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.